Archive of the Category 'Office News'
Dr. Della Valle on the Medicine of Movement Podcast
Answering the important questions for undergoing a total or partial knee replacement. Here, we discuss understanding the severity of arthritis and how to help patients make more informed decisions. Thank you, Dr. Yanke, for having me on the Medicine of Movement podcast.
Dr. Della Valle Was Main Speaker for the HKU Arthroplasty Webinar
As we begin to see the emergence of in-person meetings and academic conventions, I was honored as the main speaker for the HKU Arthroplasty webinar on outpatient joint arthroplasty surgery techniques of lateral unicompartmental knee arthroplasties. Both topics continue to grow in our ever-changing world of adult reconstruction.
National Arthritis Awareness Month
In honor of National Arthritis Awareness Month, Dr. Della Valle would like to recognize anyone who has suffered from arthritis. He treats patients with hip and knee arthritis.
“The fun part of my job is seeing patients back soon after surgery and their pain is usually dramatically decreased or gone,” Dr. Della Valle says. “Many more people have heard the success stories of treatment and we have more and more patients coming in seeking relief. They are relieved to know that there are excellent, proven surgical options for arthritis affecting almost all parts of the body.”
Read more about arthritis management and treatment options at https://www.rushortho.com/news/national-arthritis-awareness-month-2021.
“Two thumbs up” for Dr. Della Valle and staff after partial knee replacement
When Charles Rupert, 56, of Champaign decided to do something about his nagging knee pain, he assumed a total knee replacement was in his future. With two knee surgeries already under his belt, he was willing to do whatever it might take to be comfortable standing at work and fully active again.
“I’m a big workout guy, usually in the gym three to four days a week,” he explains. “But for years, I’ve only been able to work out my upper body because of my knee pain. I just knew it was time.”
Willing to travel for the best care, he researched joint replacement physicians in Chicago and found highly rated Dr. Craig Della Valle of Midwest Orthopaedics at Rush, also Professor of Orthopedic Surgery and Chief of the Adult Reconstruction Service at Rush University Medical Center. Within days he had an appointment. “I wanted to be treated by the best in Chicago,” he says.
Continue Reading on the Midwest Orthopaedics at Rush web site »
Dr. Della Valle at the ISHKS in Bangalore, India
Dr. Della Valle was invited to speak at the Indian Society of Hip and Knee Surgery in Bangalore, India, from April 12-14, 2019.
From Dr. Della Valle:
“I Had the great pleasure of traveling to India along with AAHKS past president Bill Jiranek to present at the Indian Society of Hip and Knee Surgery which was attended by approximately 400 surgeons who specialize in hip and knee surgery. Over three days I engaged in approximately 10 lecturers ranging from primary to revision hip and knee arthroplasty. The hospitality was incredible and the scientific content of the meeting impressive. It was an honor to be a part of their meeting and to share our work and experiences with them!”
Click here for an article on the meeting from AAHKS. To learn more about the ISHKS, visit ishks.com.
Dr. Della Valle’s Study wins MAOA Poster Award
Dr. Della Valle’s study entitled “A Multi-center Randomized Clinical Trial of Tranexamic Acid in Revision Total Knee Arthroplasty: Does the Dosing Regimen Matter?” was selected as one of two posters to win the Poster Award at the 2019 Mid-America Orthopaedic Association annual meeting.
For more information on MAOA, please visit www.maoa.org.
Dr. Della Valle’s Manuscript One of Top Three Abstracts for 2019 Rush Surgical Society Annual Meeting
Dr. Della Valle’s manuscript, “Large Opioid Prescriptions Are Unnecessary After Total Joint Arthroplasty: A Randomized Controlled Trial” has been awarded one of the top three abstracts for the 2019 Rush Surgical Society Annual Meeting.
About the manuscript: A majority of patients in the United States receive over 90 opioid pills after hip or knee replacement surgery. The results from this study found that these large opioid prescriptions are unnecessary as they leave patients with an excess of unused opioid pills. A smaller prescription of 30 opioid pills is sufficient for a majority of patients undergoing hip or knee replacement.
Dr. Della Valle’s Manuscript Wins Carl L. Nelson, M.D. Physician in Training Award
Dr. Della Valle’s manuscript, “Large Opioid Prescriptions Are Unnecessary After Total Joint Arthroplasty: A Randomized Controlled Trial” has won the $1,000 Carl L. Nelson, M.D. Physician in Training Award. The Program Committee of the Mid-America Orthopaedic Association has selected the paper and three other papers for prizes.
About the manuscript: A majority of patients in the United States receive over 90 opioid pills after hip or knee replacement surgery. The results from this study found that these large opioid prescriptions are unnecessary as they leave patients with an excess of unused opioid pills. A smaller prescription of 30 opioid pills is sufficient for a majority of patients undergoing hip or knee replacement.
Dr. Della Valle’s Paper Wins The Knee Society’s Mark Coventry, MD Award
Dr. Della Valle’s paper entitled, “A Multi-center Randomized Clinical Trial of Tranexamic Acid in Revision Total Knee Arthroplasty: Does the Dosing Regimen Matter?” has won The Knee Society’s Mark Coventry, MD Award.
Revision total knee arthroplasty is a complex surgery that has a higher risk of blood loss than primary total knee arthroplasty. In this multi-center, prospective, randomized controlled trial we evaluated different dosing and administration routes of tranexamic acid, a medication shown to reduce blood loss after primary and revision total knee arthroplasty. This study found that all tranexamic dosing regimens were similarly effective methods of blood management in revision total knee arthroplasty. This study supports that surgeons should consider using the lowest effective dose and the least costly regimen for tranexamic acid use in revision total knee arthroplasty.
The paper will be presented at The Knee Society/AAHKS Specialty Day program (AAOS 2019 Annual Meeting) on Saturday, March 16, in Las Vegas, NV.
Dr. Della Valle Manuscript Awared the 2018 James A. Rand Young Investigator’s Award
Dr. Della Valle recently co-authored a manuscript entitled “Large Opioid Prescriptions are Unnecessary after Total Joint Arthroplasty: A Randomized Controlled Trial”. The manuscript was awarded the 2018 James A. Rand Young Investigator’s Award to be presented at the AAHKS meeting November 1-4 in Dallas, TX.
About the study: “A majority of patients in the United States receive over 90 opioid pills after hip or knee replacement surgery. The results from this study found that these large opioid prescriptions are unnecessary as they leave patients with an excess of unused opioid pills. A smaller prescription of 30 opioid pills is sufficient for a majority of patients undergoing hip or knee replacement.”
